Expert Opinion on Drug Metabolism & Toxicology · 1×
×1.314k/11kPHARM
×2.22k/757TRANS
×1.010k/10kONCOL
×1.47k/5kPPCH
×1.05k/5kPHARM
Citations per year
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
'26
Countries where authors publish in Pharmacogenomics
Since Specialization
Citations
This map shows the geographic impact of research published in Pharmacogenomics. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Pharmacogenomics with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pharmacogenomics more than expected).
This network shows the impact of papers published in Pharmacogenomics. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Pharmacogenomics.
About Pharmacogenomics
The 2.7k papers published in Pharmacogenomics in the last decades have received a total of 64.4k indexed citations . Papers published in Pharmacogenomics usually cover Pharmacology (756 papers), Transplantation (72 papers), Pediatrics, Perinatology and Child Health (293 papers), Oncology (379 papers) and Genetics (333 papers) specifically the topics of Pharmacogenetics and Drug Metabolism (741 papers), Drug Transport and Resistance Mechanisms (173 papers), Pharmaceutical studies and practices (143 papers), Pharmacological Effects and Toxicity Studies (125 papers), Computational Drug Discovery Methods (113 papers), Genetic Associations and Epidemiology (103 papers), Gene expression and cancer classification (98 papers) and Bioinformatics and Genomic Networks (90 papers). The most active scholars publishing in Pharmacogenomics are Frances J. Sharom, L. DiAnne Bradford, Howard L. McLeod, Simon T. Bennett, Mikko Niemi, David F. Lewis, Cédric Notredame, Gary Hardiman, Anton A. Komar and Carl T. Wittwer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.